Both in Pharmaceuticals
Trevi Therapeutics vs Schrodinger
Over the past year TRVI returned +27.1% and SDGR returned +35.9%; their daily moves had a correlation of 0.17.
TRVI +27.1% SDGR +35.9%Growth of $1, one year, split-adjusted
| Metric | TRVI | SDGR |
|---|---|---|
| Price | $13.35 | $30.12 |
| Market cap | $1.90B | $2.25B |
| Today | 0.00% | +12.72% |
| 1 month | −7.4% | −0.7% |
| 6 months | −3.4% | +156.1% |
| Year to date | +6.6% | +68.5% |
| 1 year | +27.1% | +35.9% |
| Revenue growth (YoY) | — | +7.5% |
| Gross margin | — | 55.1% |
| Net margin | — | 10.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 8.7× |
| Net cash | $318.9M | $413.7M |
| Dividend yield | — | — |
| Volatility (60d) | 39.0% | 90.9% |
| Short % of float | 14.4% | 19.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).